Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-05-03
1985-04-23
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514617, 514621, A61K 3152
Patent
active
045129940
ABSTRACT:
Long-acting forms of theophylline for use in treating asthma comprise theophylline associated with a compound of the substituted cinnamamide type of the general formula ##STR1## wherein R is hydrogen, a hologen or an acetyl radical; R.sub.1 is hydrogen or the methyl radical; R.sub.2 is ##STR2## wherein R.sub.3 is hydrogen or the methyl radical; or R.sub.1 and R.sub.2 together with the adjacent nitrogen tom form the 2,2-dimethyl-3-oxazolidinyl group.
REFERENCES:
patent: 3780102 (1973-12-01), Bayssat et al.
Cutting's Handbook of Pharmacology, 4th Ed., 1967, pp. 294-296.
Chemical Abstracts vol. 92, Jun. 23, 1980, No. 25 (92: 208747f Inhibition by Idrocilamide of the Disposition of Caffeine)(J. L. Brazier) 1-Pharmacodynamics.
European Journal of Medicinal Chemistry (Chimica Therapeutica) vol. IX, Sep.-Oct. 1974, No. 5.
Bayssat Michel
Belleville Maryse
Grand Marcel
Lipha Lyonnaise Industrielle Pharmaceutique
Schenkman Leonard
LandOfFree
Long-acting theophylline in medicinal form does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Long-acting theophylline in medicinal form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long-acting theophylline in medicinal form will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36756